Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Aristotle has finally launched...
View:
Post by johnny007 on Jul 08, 2021 9:52am

Aristotle has finally launched...

FWIW, Aristotle has finally launched as visible on StageZero's _and_ Care Oncology's website.
StageZero also finally added an employer link for big companies etc.

Assuming SP will at least recover to C$0.80 if market is not yet welcoming the CoC acquisition with open arms - instead of C$1.50.

At least we can say, shares of StageZero are available at a very very low price these days :)
Comment by LithLover on Jul 08, 2021 10:09am
We are not active on the Care Oncology website.  Through digging the link was found  https://careoncology.com/aristotle/   There is a learn more button for employers that doesn't work and a form to request info.  If you go to their home page on their website there is not a tab or way I see to get to Aristotle. You have to paste the link above. I suspect this will ...more  
Comment by johnny007 on Jul 08, 2021 10:22am
Same page work on Stagezero's website though, incl. the employer info. https://www.stagezerolifesciences.com/aristotle-test.html https://www.stagezerolifesciences.com/aristotle.html - Submit works - Employer works https://www.stagezerolifesciences.com/employers.html - Employer AVRT Aristotole site +++ https://careoncology.com/aristotle/ - Submit works - Employer disabled +++ in the ...more  
Comment by Mykndrsn on Jul 08, 2021 10:35am
Response from AVRT inquiry. Everything in holding pattern for the moment. Your submission form for the AVRT program has been received. WELCOME to Stage Zero Life Sciences’ comprehensive telehealth program that uses advanced diagnostics and evidence based clinical protocols to keep individuals informed and to reduce the risk of developing cancer and other chronic diseases. This is the first step ...more  
Comment by molotov420 on Jul 08, 2021 10:44am
Ok....so no sales from new clients in Q2 I guess....hopefully there will be something from existing care patients. SMH
Comment by TrippinAgain22 on Jul 08, 2021 10:48am
This post has been removed in accordance with Community Policy
Comment by johnny007 on Jul 08, 2021 11:06am
To Tripping and Molotov, of course - sales number for Aristotole will be low and not at all meaningful as they just have launched this product / diagnosis package. This, regardless whether they actually launched in April or June. It is not like the world knew about their product and has waited, now begging to get eligible :) Every launch takes time. I am just stating, that they broadened ...more  
Comment by johnny007 on Jul 08, 2021 11:09am
to complement the above, 2Q + 3Q sales number will mostly be high due to covid testing of course and another big beat expected with positive EBITDA. 3Q might be interesting, as it shall contain CoC financial and performance.
Comment by molotov420 on Jul 08, 2021 11:10am
It's true, this is actual in line with what they stated. Available to existing Care patients first. So no surprise really. Just tired of seeing red every day!
Comment by IainCaimbeul on Jul 08, 2021 11:23am
Molotov, don't worry about the red, gojo said earlier in the week that we would be at $0.60 by this Friday. As of right now  that would be a gap up of $0.17. 
Comment by molotov420 on Jul 08, 2021 11:24am
Looool, thanks for the laugh. 
Comment by Liked2Think on Jul 08, 2021 11:49am
I dont think anyone believed Aristotle really launched April 1.  Tripp was backed into a corner cause he said it would launch Q1 and unlike the major healthcare provider being named and the $30M in revenue that never came they could actually hurry this up and say it on a technicality.   There is no doubt in my mind that they havent done any aristotle tests for Q2.  Hopefully ...more  
Comment by capebretongirl on Jul 08, 2021 12:25pm
Thanks for the privileged insight and worldly opinions.  I am sure we can count on you to repeat that $30 M overstep and the unidentified healthcare provider at least another 10 times by market close Friday.......
Comment by Pacman28 on Jul 08, 2021 1:06pm
You call all of Tripps predictions oversteps... Fine, I'll give You that. Totally messing up the Aristotle rollout, or 180 degree about face is however way bigger than an overstep. It's literally why we're at 42 cents and not $4.20. And You know that urself
Comment by Liked2Think on Jul 08, 2021 3:11pm
I think thats the 2nd time I have brought it up this year.  But yeah Im wrong to bring it up.  We should forget we were "missinformed" by such a large extent by our ceo and move on. No chance we will be "missinformed" again.  What was I thinking. OH $0.425 cents a share now.  Another good sign.
Comment by VerifiedUser123 on Jul 08, 2021 5:47pm
It is true though. Very comical for a professional CEO to come out and say that but finish the year with 30k. More a testament to our board than anything. A legitimate board made of competent people would have ousted our joke and fraudster (in my humble opinion) of a CEO. Show me another CEO who's made that gaff and survived
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities